bone grafts bone graft substitutes and biologics like BMPs Risk of adverse reactions (e.g., inflammatory responses) Potential for graft resorption or failure Regulatory issues surrounding biologic agents Variability in clinical outcomes depending on patient fact A April Schultz Mar 18, 2026